Singapore-headquartered PatSnap is looking to strengthen its presence in the international markets such as Germany, France and Japan, besides augmenting its database in pharmaceutical research, its co-founder Guan Dian told DealStreetAsia in an interview.
The company made headlines last week when it raised $300 million in its Series E round led by SoftBank Vision Fund 2 and Tencent Investment, thereby entering the coveted unicorn club with its valuation topping $1 billion.
